Knoll Capital Management’s Evoke Pharma EVOK Stock Holding History

Knoll Capital Management’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,910	Closed	-$682K	–	18
2018 Q4	$682K	Hold	1,910	–	–	0.78%	12
2018 Q3	$825K	Hold	1,910	–	–	0.7%	14
2018 Q2	$688K	Hold	1,910	–	–	0.58%	15
2018 Q1	$572K	Hold	1,910	–	–	0.59%	12
2017 Q4	$622K	Buy	1,910 +347	+22%	+$144K	0.55%	11
2017 Q3	$752K	Buy	1,563 +348	+29%	+$134K	0.64%	13
2017 Q2	$448K	Hold	1,215	–	–	0.59%	13
2017 Q1	$543K	Buy	+1,215	New	+$498K	0.82%	15
2016 Q3	–	Sell	-387	Closed	-$381K	–	19
2016 Q2	$381K	Hold	387	–	–	0.12%	17
2016 Q1	$283K	Hold	387	–	–	0.11%	20
2015 Q4	$184K	Hold	387	–	–	0.07%	19
2015 Q3	$162K	Hold	387	–	–	0.07%	17
2015 Q2	$291K	Buy	387 +13	+3%	+$11.1K	0.09%	17
2015 Q1	$380K	Buy	+374	New	+$337K	0.11%	15

Other funds holding EVOK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Knoll Capital Management's EVOK Position: Q1 2019 in Review

Knoll Capital Management sold out of Evoke Pharma (EVOK) in Q1 2019, closing a stake of 1,910 shares — an estimated $682K sold.

Knoll Capital Management first reported a position in EVOK in Q1 2015 and held it in 14 quarters. The position peaked at $825K in Q3 2018. 22 funds tracked by Wall St. Rank hold EVOK as of Q1 2019.

Knoll Capital Management reported no remaining Evoke Pharma position as of Q1 2019 after selling out during the quarter.
Knoll Capital Management sold 1,910 Evoke Pharma shares in Q1 2019, an estimated $682K.
Knoll Capital Management first reported a position in Evoke Pharma in Q1 2015 and held it in 14 quarters.
Knoll Capital Management's Evoke Pharma position peaked at $825K in Q3 2018.
22 funds tracked by Wall St. Rank held Evoke Pharma as of Q1 2019.

Based on Knoll Capital Management's 13F filing for Q1 2019, filed 15 May 2019.